Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thome

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review articleJ Thome, P Foley, P Riederer
Psychiatrische Praxis|November 27, 2001
[Paroxetine augmentation with risperidone in therapy-resistant depression]U Knopf, P Hubrich-Ungureanu, J Thome
Biological Psychiatry|November 24, 1999
Neural plasticity to stress and antidepressant treatmentR S Duman, J Malberg, J Thome
Molecular Psychiatry|March 14, 2007
A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoformsR Donev, A Newall, J Thome, et al.
Biological Psychiatry|April 15, 1997
Apolipoprotein E-epsilon 4 allele frequency in late-onset depressionA Heidrich, J Thome, M Rösler, et al.
Journal of Neural Transmission. Supplementum|December 16, 1998
Free radicals in Alzheimer's dementia: currently available therapeutic strategiesM Rösler, W Retz, J Thome, et al.
Journal of Psychopharmacology (Oxford, England)|December 21, 2012
MDMA can increase cortisol levels by 800% in dance clubbersAc Parrott, J Lock, L Adnum, et al.
Fortschritte Der Neurologie-Psychiatrie|April 1, 1994
[Carbamazepine in treatment of alcohol withdrawal syndrome--an overview of current research]J Thome, G A Wiesbeck, G H Vince
Psychiatrische Praxis|July 1, 1995
[Zolpidem dependence and depression in the elderly]J Thome, M Ruchsow, M Rösler, et al.
Neuroscience|November 29, 2011
The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in miceS M O'Keeffe, J Thome, A N Coogan
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review articleJ Thome, P Foley, P Riederer
Psychiatrische Praxis|November 27, 2001
[Paroxetine augmentation with risperidone in therapy-resistant depression]U Knopf, P Hubrich-Ungureanu, J Thome
Biological Psychiatry|November 24, 1999
Neural plasticity to stress and antidepressant treatmentR S Duman, J Malberg, J Thome
Molecular Psychiatry|March 14, 2007
A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoformsR Donev, A Newall, J Thome, et al.
Biological Psychiatry|April 15, 1997
Apolipoprotein E-epsilon 4 allele frequency in late-onset depressionA Heidrich, J Thome, M Rösler, et al.
Journal of Neural Transmission. Supplementum|December 16, 1998
Free radicals in Alzheimer's dementia: currently available therapeutic strategiesM Rösler, W Retz, J Thome, et al.
Journal of Psychopharmacology (Oxford, England)|December 21, 2012
MDMA can increase cortisol levels by 800% in dance clubbersAc Parrott, J Lock, L Adnum, et al.
Fortschritte Der Neurologie-Psychiatrie|April 1, 1994
[Carbamazepine in treatment of alcohol withdrawal syndrome--an overview of current research]J Thome, G A Wiesbeck, G H Vince
Psychiatrische Praxis|July 1, 1995
[Zolpidem dependence and depression in the elderly]J Thome, M Ruchsow, M Rösler, et al.
Neuroscience|November 29, 2011
The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in miceS M O'Keeffe, J Thome, A N Coogan
Pageof 17